
Avicanna Inc faced a challenging trading session, leading to a notable decline in its stock price.
In yesterday's trading session, Avicanna Inc (AVCN.TO) saw its stock price drop by 3.70%, closing at CA$0.13. This decline reflects ongoing concerns about the company's performance and market conditions.
Investor takeaway: Investors should monitor Avicanna's financial health closely, especially given its recent performance and the lack of significant news to bolster confidence.
Advertisement
Avicanna Inc
AVCN.TO
AVCN.TO
Avicanna Inc
Market cap
$17.47M
52W high
$0.30
52W low
$0.10
1W change
-3.70%
Beta
0.33
Analyst Price Targets
Based on analyst covering AVCN
Wall Street analysts forecast AVCN stock price to rise 438.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+438.5% Upside
Current Price
C$0.13
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
66.8%
Annualized
90-Day Vol
66.4%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.13
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.13 | C$0.10 – C$0.16 |
| 60 trading days | C$0.13 | C$0.09 – C$0.18 |
| 90 trading days | C$0.13 | C$0.09 – C$0.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Avicanna Inc's stock down 3.70%
With a market cap of CA$17.47 million, the stock's decline highlights investor skepticism about its growth prospects.
Bull case
Despite the recent drop, Avicanna has potential in its product lines, particularly the QUIX™ rapid-onset medical cannabis portfolio, which could drive future growth.
Bear case
The stock's continued downward trend raises concerns about the company's operational efficiency and market strategy, especially in a competitive cannabis landscape.
Recent Performance Overview
Advertisement
Avicanna Inc experienced a decline in its stock price during yesterday's session, dropping 3.70%. This performance may indicate broader market trends or specific challenges faced by the company as it navigates the competitive cannabis industry.
Market Sentiment and Future Outlook
The decline in Avicanna's stock raises concerns among investors about its operational strategy and market positioning. With a market cap of CA$17.47 million, the company needs to show strong growth to regain investor confidence. Upcoming product launches and financial results will be critical to watch.
Key Financial Metrics
Avicanna's current financial metrics show a profit margin of -12.09%, with no P/E ratio available. These figures highlight the challenges the company faces in achieving profitability, complicating the investment landscape for potential shareholders.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


